Does research into new Alzheimer's treatments reflect what matters most to those living with the disease and their care partners? When new drugs become available, will they address the symptoms and make the changes in people’s lives that are most important to them? Researcher Brett Hauber of RTI Health Solutions discusses the new What Matters Most Study. UsAgainstAlzheimer’s and its partners are launching this study to learn what matters most to those living with Alzheimer’s, so that insights from those with Alzheimer's and their care partners are considered as drugs are developed, approved, and brought into patient’s lives.

Support the show (https://www.usagainstalzheimers.org)